About
About us
At Inthera Pharma Group, our Technology Platforms are supported by Seatrack International Group’s manufacturing capabilities and a global supply chain. These platforms encompass everything from API development and formulation services to commercial cGMP manufacturing and pharma logistics.
Each platform is overseen by dedicated directors and supervisors, with support from marketing, sales teams, and our main operational office in India. All manufacturing processes occur within designated Clean Areas at Plant Chemistry I, ensuring product quality throughout.
Our integrated Technology Platforms streamline the supply chain, offering clients access to API and finished dosage development, along with packaging services. This approach simplifies technology transfers, reduces risk, and accelerates production and delivery timelines. Inthera Pharma Group is committed to delivering comprehensive pharmaceutical solutions efficiently and with unwavering quality.
Company Facts
Inthera Pharma Group, in partnership with Seatrack International Group, is a leading cGMP Contract Development and regulatory service provider.
We specialize in manufacturing Active Pharmaceutical Ingredients (APIs), Finished Drug Products, and Pharma Packaging Services. Our goal is to empower pharmaceutical and biotechnology companies to achieve product success, ultimately benefiting patients’ health.
Committed to innovation, we focus on research-intensive bio pharmaceuticals and utilize advanced technologies like Lyophilization, Nanotechnology, Drug experimentation on simulation models, as well as expertise in Peptides, Injectables, Small Molecules, and more. We are dedicated to delivering high-quality, cost-effective solutions for today and the future, supporting better lives for all.
Our Parent Company
Parent Company (Seatrack International Tradex Pvt. Ltd.) of INTHERA PHARMAMED BIOTECH has regular supplies/export to Latin American Countries on a long-term contract basis and has various products registered with respective departments.
In addition to this organization has a strong presence in Mexico, UAE, Iran, Thailand & Turkey. More details about both organizations can be found by visiting www.seatrackinternational.com
INTHERA has a license with the Central Drugs Standard Control Organization (CDSCO) with license number WLF21B2023DL000726, For the Supply of Pharmaceutical Products.
